The announcement from global drug manufacturer Pfizer that the rollout of its messenger RNA Sars-CoV-2 vaccine is only weeks away, with an efficacy of about 90%, sent retail and other consumer stocks rocketing on world equity markets.

It’s understandable, as people are now highly fatigued from this virus, desperate to claim their lives back, including shopping in an unfettered environment. ..

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now